Study finds hepatitis C cure saved Medicaid $15 billion
New research published in theAmerican Journal of Managed Care (AJMC) underscores the critical role that medicines play in improving health and reducing disease complications and other, often costly, medical care and services. The study finds that since curative direct-acting antiviral medications for hepatitis C were approved in 2013, even after factoring in the cost of treatment, Medicaid has saved an estimated $15 billion in avoided health care costs and nearly 285,000 Medicaid enrollees are estimated to have been cured.
Source: The Catalyst - Category: Pharmaceuticals Authors: Lindsey Seidlitz Tags: Drug Cost Hepatitis C Medicaid Source Type: news
More News: Health Management | Hepatitis | Hepatitis C | Managed Care | Medicaid | Pharmaceuticals | Study